Explore NSN 6505-01-387-7648 Parts Catalog - (NDC51672-1259-03, NDC00173-0376-02) under Clobetasol Ointment

NSN 6505-01-387-7648 is a Clobetasol Ointment part manufactured by Taro Pharmaceuticals Usa Inc, Glaxo Wellcome Inc. These items are compliant with fit, form, and functionality according to parameters set by the DLA. With over 3 billion new and obsolete NSN parts in our searchable NSN database, you can find your required NSN 6505-01-387-7648 parts with ease. We maintain an unmatched supply-chain network with trusted MFRs and verified PMAs. Do you require NSN part numbers other than NDC51672-1259-03, NDC00173-0376-02? Related NSN parts defined by FSC 6505 Drugs and Biologicals are listed below.

NSN 6505-01-387-7648 Information

Alternative NSN: 6505-01-387-7648
Item Name: Clobetasol Ointment
Federal Supply Class (FSC): 6505 Drugs and Biologicals
NIIN: 013877648
NCB Code: USA (01)
Manufacturers: Glaxo Wellcome Inc , Taro Pharmaceuticals Usa Inc

6505-01-387-7648 (6505013877648) - Clobetasol Ointment Part Details

Part No Manufacturer Item Name QTY RFQ
NDC51672-1259-03 taro pharmaceuticals usa inc clobetasol ointment Avl RFQ
NDC00173-0376-02 glaxo wellcome inc clobetasol ointment Avl RFQ

Characteristics Data of NSN 6505013877648

MRCCriteriaCharacteristic
CXCYPART NAME ASSIGNED BY CONTROLLING AGENCYCLOBETASOL OINTMENT 60GM TUBE
TEXTGENERAL CHARACTERISTICS ITEM DESCRIPTION0.05 % CLOBETASOLE PROPIONATE; 60 GRAM TUBE

Send Instant RFQ

Low Price

Warrantied inventory at competitive prices

Find it Fast

Search the world's largest inventory of electronic components by manufacturer, category or part number

Quality Guaranteed

We sell only warrantied and traceable parts

Get it Fast

All inventory ready to ship from our sellers

Semiconductor's Certifications and Memberships

Thank You for Visiting.

We Hope that You'll Choose Buy Aviation Parts as Your Quick and Convenient Parts Distributor In the Future.

Request for Quote

We use cookies to ensure that we give you an amazing browsing experience on our website. If you continue to use this site we will assume that you are happy with it.